264 related articles for article (PubMed ID: 25059234)
1. Predictive value of systemic and local inflammation parameters in talc pleurodesis assessment.
Habal P; Omran N; Jankovicova K; Krejsek J; Mandak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):234-41. PubMed ID: 25059234
[TBL] [Abstract][Full Text] [Related]
2. New biomarkers in the selection of patients for talcage of pleural cavity in the palliative therapy of malign pleural exudate.
Habal P; Omran N; Chek J; Krejsek J; Mandak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):576-81. PubMed ID: 25690520
[TBL] [Abstract][Full Text] [Related]
3. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
Leemans J; Dooms C; Ninane V; Yserbyt J
Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
[TBL] [Abstract][Full Text] [Related]
4. [The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].
Hoksch B; Seidel N; Beshay M; Schmid RA
Zentralbl Chir; 2010 Feb; 135(1):54-8. PubMed ID: 20029741
[TBL] [Abstract][Full Text] [Related]
5. Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set.
Mercer RM; Macready J; Jeffries H; Speck N; Kanellakis NI; Maskell NA; Pepperell J; Saba T; West A; Ali N; Corcoran JP; Hallifax RJ; Psallidas I; Asciak R; Hassan M; Miller RF; Rahman NM
Respirology; 2020 Jul; 25(7):750-755. PubMed ID: 31846131
[TBL] [Abstract][Full Text] [Related]
6. The dynamics of selected local inflammatory markers to talc in the treatment of malignant pleural effusions.
Habal P; Jankovicova K; Omran N; Kondelkova K; Krejsek J; Mandak J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):311-5. PubMed ID: 23235721
[TBL] [Abstract][Full Text] [Related]
7. Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.
Bhatnagar R; Luengo-Fernandez R; Kahan BC; Rahman NM; Miller RF; Maskell NA
Health Technol Assess; 2020 Jun; 24(26):1-90. PubMed ID: 32525474
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
9. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
[TBL] [Abstract][Full Text] [Related]
10. Perspective in predicting the effect of pleurodesis in the treatment of malignant pleural effusions.
Habal P; Omran N; Kovacicova K; Chek J; Jankovicova K; Mandak J
Bratisl Lek Listy; 2015; 116(5):285-8. PubMed ID: 25924636
[TBL] [Abstract][Full Text] [Related]
11. [Monitoring the effectiveness of surgical treatment of malignant pleural effusions].
Habal P; Mand'ák J; Simek J; Stĕtina M; Jankovicová K; Kondĕlková K; Krejsek J
Klin Onkol; 2010; 23(2):99-103. PubMed ID: 20465088
[TBL] [Abstract][Full Text] [Related]
12. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
13. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
[TBL] [Abstract][Full Text] [Related]
14. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory parameters after pleurodesis in recurrent malignant pleural effusions and their predictive value.
Ukale V; Agrenius V; Widström O; Hassan A; Hillerdal G
Respir Med; 2004 Dec; 98(12):1166-72. PubMed ID: 15588036
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
Verma A; Taha A; Venkateswaran S; Tee A
Singapore Med J; 2015 May; 56(5):268-73. PubMed ID: 26034319
[TBL] [Abstract][Full Text] [Related]
17. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
18. TLR2 in pleural fluid is modulated by talc particles during pleurodesis.
Jankovicova K; Kondelkova K; Habal P; Andrys C; Krejsek J; Mandak J
Clin Dev Immunol; 2012; 2012():158287. PubMed ID: 23304186
[TBL] [Abstract][Full Text] [Related]
19. Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases.
Barbetakis N; Asteriou C; Papadopoulou F; Samanidis G; Paliouras D; Kleontas A; Lyriti K; Katsikas I; Tsilikas C
J Cardiothorac Surg; 2010 Apr; 5():27. PubMed ID: 20403196
[TBL] [Abstract][Full Text] [Related]
20. [Radiological changes of talc pleurodesis in cases of effusion].
Carignan S; Samson L; Lafontaine E; Cordeau MP
Ann Chir; 1994; 48(8):777-84. PubMed ID: 7872630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
